SCHEMBL17278511

SCHEMBL17278511

CC(C)(C)c1ccc(-c2nc(-c3ccc(N4c5ccccc5Oc5ccccc54)cc3)nc(-c3ccc(C(C)(C)C)cc3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 6/20 0.43
▸ NPC1 O15118 5/20 0.43
▸ TP53 P04637 4/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ HDAC6 Q9UBN7 1/20 0.38
▸ LMNA P02545 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ ABCG2 Q9UNQ0 1/20 0.36
▸ S1PR1 P21453 1/20 0.35
▸ TNF P01375 1/20 0.35
▸ NOD1 Q9Y239 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ XDH P47989 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31059182 0.88 P2RX4 (0.39) SMN1; SMN2MEN1KMT2AMAPTHPGD
SCHEMBL16271056 0.88 P2RX4 (0.39) SMN1; SMN2MEN1KMT2AMAPTHPGD
SCHEMBL14932219 0.88 P2RX4 (0.38) SMN1; SMN2LMNAMAPTTSHRNPSR1
SCHEMBL23251154 0.87 TP53 (0.34) RAB9ANPC1TP53SMN1; SMN2MEN1
SCHEMBL21915375 0.85 CYP19A1 (0.39) RAB9ANPC1TP53SMN1; SMN2MEN1
SCHEMBL17278486 0.85 TP53 (0.37) RAB9ANPC1TP53SMN1; SMN2MEN1
SCHEMBL30767826 0.85 P2RX4 (0.40) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL16271063 0.85 P2RX4 (0.40) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL29358029 0.85 P2RX4 (0.40) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL16271052 0.85 P2RX4 (0.40) RAB9ANPC1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11730052-B2 Light-emitting device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-15 — — US disclosed
US-11730052-B2 Light-emitting device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-15 — — US disclosed
US-20190109285-A1 ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2019-04-11 — — US disclosed
US-10186665-B2 Organic electroluminescent element IDEMITSU KOSAN CO., LTD. (JP) 2019-01-22 — — US disclosed
US-9882144-B2 Organic electroluminescent element IDEMITSU KOSAN CO., LTD. (JP) 2018-01-30 — — US disclosed
US-9882144-B2 Organic electroluminescent element IDEMITSU KOSAN CO., LTD. (JP) 2018-01-30 — — US disclosed
US-20160197287-A1 ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2016-07-07 — — US disclosed
US-20160197287-A1 ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2016-07-07 — — US disclosed
US-20160028025-A1 LIGHT-EMITTING DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-01-28 — — US disclosed
US-20160028025-A1 LIGHT-EMITTING DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-01-28 — — US disclosed
US-20150340623-A1 ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2015-11-26 — — US disclosed
US-20150340623-A1 ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2015-11-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190109285-A1 ORGANIC ELECTROLUMINESCENT ELEMENT TCF4, TRPA1, EML4 RAB9A 1741/4885NPC1 2912/4885TP53 2404/4885
US-11730052-B2 Light-emitting device GRK7, GRK1, CTNND1 RAB9A 808/4885NPC1 2689/4885TP53 4105/4885
US-10186665-B2 Organic electroluminescent element TCF4, TRPA1, EML4 RAB9A 1741/4885NPC1 2912/4885TP53 2404/4885
US-20160197287-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AOC2, AZI2, RER1 RAB9A 2437/4885NPC1 1304/4885TP53 4159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback